Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Cheol Lee

Showing results (221-230 of 226) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 226 results.
Nature Cancer|June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Jinhyeon An, Soohyeon Lee, et al.
Nature Communications|November 23, 2024
Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironmentKyu Jin Song, Seunghyuk Choi, Kwoneel Kim, et al.
Cancer Research and Treatment|November 7, 2023
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort StudySongji Choi, Seyoung Seo, Ju Hyun Lee, et al.
Cancer Medicine|December 10, 2021
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter studyJwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, et al.
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Nature Genetics|July 4, 2012
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerZhenfeng Zhang, Jae Cheol Lee, Luping Lin, et al.
Pageof 23

Showing results (221-230 of 226) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Nature Cancer|June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Jinhyeon An, Soohyeon Lee, et al.
Nature Communications|November 23, 2024
Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironmentKyu Jin Song, Seunghyuk Choi, Kwoneel Kim, et al.
Cancer Research and Treatment|November 7, 2023
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort StudySongji Choi, Seyoung Seo, Ju Hyun Lee, et al.
Cancer Medicine|December 10, 2021
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter studyJwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, et al.
Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.
Nature Genetics|July 4, 2012
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerZhenfeng Zhang, Jae Cheol Lee, Luping Lin, et al.
Pageof 23